SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF
The trial enrolled just half of its planned patients, leaving spironolactone’s role in HFpEF and HFmrEF still up…
Browsing Tag